 The primary endpoint is the trabecular bone score TBS, which is derived from the antero-posterior spine raw DXA images from the same region of interest as the BMD measurement by the use of a specific software and correlates with three-dimensional bone micro-architecture parameters. Among the numerous potential measures of bone quality, TBS is the only one that has been consistently shown to be lower in T2DM vs. control subjects. 